학술논문

Risk–Benefit Analysis of Primary Prophylaxis Against Pneumocystis Jirovecii Pneumonia in Patients With Rheumatic Diseases Receiving Rituximab
Document Type
Article
Source
In: Arthritis and Rheumatology. (Arthritis and Rheumatology, November 2023, 75(11):2036-2044)
Subject
Language
English
ISSN
23265205
23265191